Orphan drugs—access and unmet needs in 194 countries and six regions: a comprehensive policy review with content analysis
Adrienne Y L Chan(Aston University), Xue Li(Department of Health), Mengchun Gong(National Bureau of Statistics of China), Esther W. Chan(University of Hong Kong), Brian Hon‐Yin Chung(Long Island Jewish Medical Center), Patrick Ip(University of Hong Kong), Gloria Hoi Yan Wong(University of Hong Kong), Mark Jit(London School of Hygiene & Tropical Medicine), Terry Yat Sang Lum(University of Hong Kong), Shuyang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ian Chi Kei Wong(Blacktown & Mount Druitt Hospital), Claudia Ching Yan Chung(University of Hong Kong), Sten Olsson, Swathi Pathadka(University of Hong Kong), Vivien Kin Yi Chan(University of Hong Kong), Celine Sze Ling Chui(University of Hong Kong), Mengqin Ge(University of Hong Kong), Min Fan(University of Hong Kong)
Cited by 5
Related Papers
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
|The Lancet Global Health|2020|1.2k
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism
|Nature Genetics|2022|613
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality
|Journal of Bone and Mineral Research|2023|506
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
|Health Policy|2021|315